Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2011 by Zhejiang Cancer Hospital
Sponsor:
Information provided by (Responsible Party):
Zhejiang Cancer Hospital
ClinicalTrials.gov Identifier:
NCT01463501
First received: August 30, 2011
Last updated: May 11, 2013
Last verified: September 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)